Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL761P is a pseudogene derived from the 7SL RNA gene family, specifically classified as "RNA, 7SL, cytoplasmic 761, pseudogene." The 7SL RNA gene encodes the RNA component of the signal recognition particle (SRP), which plays a vital role in targeting secretory proteins to the endoplasmic reticulum membrane[3][5]. In contrast, RN7SL761P is a non-functional, non-coding genomic DNA sequence that resembles the functional 7SL RNA gene but is not transcribed into active RNA[1]. The majority of 7SL pseudogenes, including RN7SL761P, are believed to originate from the genomic integration of reverse-transcribed RNAs and typically lack biological activity[1]. RN7SL761P is not a protein-coding gene and does not produce a functional RNA or protein product[1]. There is no evidence suggesting that RN7SL761P functions as a receptor, enzyme, transport protein, or other therapeutic target. It is not implicated in pharmacological interactions or disease processes[1]. While functional 7SL RNA participates in SRP-mediated targeting of proteins, RN7SL761P is a truncated, non-functional copy and lacks biological function[1][5]. Other similarly named pseudogenes such as RN7SL676P and RN7SL361P exist; these are also non-functional genomic elements[2][4]. The designation as a pseudogene means RN7SL761P is not a standard drug target and holds no known clinical or molecular function relevant to disease mechanisms, drug interactions, or biomarker utility[1][3][5]. The entry is marked is_incorrect: true because requesting therapeutic target data for a pseudogene that is not biologically active is conceptually incorrect per field conventions. If structured information on a functional SRP RNA (7SL RNA) is required, that would be a distinct entry with functional characteristics, biological roles, and potential clinical significance[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 7SL RNA, cytoplasmic 761, pseudogene (RN7SL761P).